Published in Proc Natl Acad Sci U S A on February 26, 2002
Patterns of somatic mutation in human cancer genomes. Nature (2007) 38.41
T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus. Proc Natl Acad Sci U S A (2008) 4.74
Multiple mutations and cancer. Proc Natl Acad Sci U S A (2003) 4.21
Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia. Blood (2008) 3.89
Multistage carcinogenesis and the incidence of colorectal cancer. Proc Natl Acad Sci U S A (2002) 3.64
Genetic progression and the waiting time to cancer. PLoS Comput Biol (2007) 3.57
Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers. Proc Natl Acad Sci U S A (2008) 3.52
Human cancers express a mutator phenotype. Proc Natl Acad Sci U S A (2006) 3.11
Human cancers express mutator phenotypes: origin, consequences and targeting. Nat Rev Cancer (2011) 2.77
Mutational spectra of human cancer. Hum Genet (2009) 2.26
Mutational heterogeneity in human cancers: origin and consequences. Annu Rev Pathol (2010) 2.02
Inferring clonal expansion and cancer stem cell dynamics from DNA methylation patterns in colorectal cancers. Proc Natl Acad Sci U S A (2009) 1.98
A spatial model predicts that dispersal and cell turnover limit intratumour heterogeneity. Nature (2015) 1.66
Pretumor progression: clonal evolution of human stem cell populations. Am J Pathol (2004) 1.57
Cancer genome sequencing--an interim analysis. Cancer Res (2009) 1.52
Defining the blueprint of the cancer genome. Carcinogenesis (2008) 1.49
Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation. Genes Dev (2004) 1.48
PathScan: a tool for discerning mutational significance in groups of putative cancer genes. Bioinformatics (2011) 1.46
Intestinal adenomas can develop with a stable karyotype and stable microsatellites. Proc Natl Acad Sci U S A (2002) 1.30
High-throughput discovery of rare human nucleotide polymorphisms by Ecotilling. Nucleic Acids Res (2006) 1.28
A simple algebraic cancer equation: calculating how cancers may arise with normal mutation rates. BMC Cancer (2010) 1.16
Our changing view of the genomic landscape of cancer. J Pathol (2010) 1.13
Detection of somatic mutations by high-resolution DNA melting (HRM) analysis in multiple cancers. PLoS One (2011) 1.13
Genetic and biological subgroups of low-stage follicular thyroid cancer. Am J Pathol (2003) 1.11
Mutation and epigenetic molecular clocks in cancer. Carcinogenesis (2010) 1.07
Lack of increases in methylation at three CpG-rich genomic loci in non-mitotic adult tissues during aging. BMC Med Genet (2007) 1.04
Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas. Breast Cancer Res (2007) 1.01
Consequences of nonadaptive alterations in cancer. Mol Biol Cell (2003) 1.00
High DNA methylation pattern intratumoral diversity implies weak selection in many human colorectal cancers. PLoS One (2011) 0.98
Statistical method on nonrandom clustering with application to somatic mutations in cancer. BMC Bioinformatics (2010) 0.97
Utilizing protein structure to identify non-random somatic mutations. BMC Bioinformatics (2013) 0.96
Carcinogens induce genome-wide loss of heterozygosity in normal stem cells without persistent chromosomal instability. Proc Natl Acad Sci U S A (2006) 0.95
A graph theoretic approach to utilizing protein structure to identify non-random somatic mutations. BMC Bioinformatics (2014) 0.91
Immortality of cancers: a consequence of inherent karyotypic variations and selections for autonomy. Cell Cycle (2013) 0.89
Human hair genealogies and stem cell latency. BMC Biol (2006) 0.89
Older individuals appear to acquire mitotically older colorectal cancers. J Pathol (2009) 0.88
Modeling variation in tumors in vivo. Proc Natl Acad Sci U S A (2005) 0.84
Topography of genetic loci in the nuclei of cells of colorectal carcinoma and adjacent tissue of colonic epithelium. Chromosoma (2004) 0.84
Effect of dedifferentiation on time to mutation acquisition in stem cell-driven cancers. PLoS Comput Biol (2014) 0.83
A spatial simulation approach to account for protein structure when identifying non-random somatic mutations. BMC Bioinformatics (2014) 0.83
Is there any genetic instability in human cancer? DNA Repair (Amst) (2010) 0.83
Epithelial cancers in the post-genomic era: should we reconsider our lifestyle? Cancer Metastasis Rev (2013) 0.78
Current concepts in the molecular genetics of pediatric brain tumors: implications for emerging therapies. Childs Nerv Syst (2006) 0.78
A subgroup of microsatellite stable colorectal cancers has elevated mutation rates and different responses to alkylating and oxidising agents. Br J Cancer (2004) 0.77
Molecular tumor clocks to study the evolution of drug resistance. Mol Pharm (2011) 0.77
Direct measurements of human colon crypt stem cell niche genetic fidelity: the role of chance in non-darwinian mutation selection. Front Oncol (2013) 0.76
No mutations in the tyrosine kinases of human hepatic, pancreatic, and gastric cancer cell lines. J Gastroenterol (2005) 0.76
Reply: Is There Any Genetic Instability in Human Cancer? DNA Repair (Amst) (2010) 0.76
The Epigenomics of Embryonic Pathway Signaling in Colorectal Cancer. Front Pharmacol (2017) 0.76
An improved understanding of cancer genomics through massively parallel sequencing. Transl Cancer Res (2014) 0.75
Leveraging protein quaternary structure to identify oncogenic driver mutations. BMC Bioinformatics (2016) 0.75
Noise-driven heterogeneity in the rate of genetic-variant generation as a basis for evolvability. Genetics (2010) 0.75
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol (2000) 128.08
The sequence of the human genome. Science (2001) 101.55
Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet (1999) 24.24
Genetic instabilities in human cancers. Nature (1998) 22.76
Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet (1999) 17.09
Mutations of mitotic checkpoint genes in human cancers. Nature (1998) 11.20
Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development (1990) 8.37
Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res (1995) 5.26
A mutator phenotype in cancer. Cancer Res (2001) 4.41
Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet (1999) 4.16
Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet (1996) 4.09
Genetic control of mutation rates in bacteriophageT4. Nature (1969) 4.06
Mad-related genes in the human. Nat Genet (1996) 2.51
The onset and extent of genomic instability in sporadic colorectal tumor progression. Proc Natl Acad Sci U S A (1999) 2.41
CELL PROLIFERATION KINETICS IN THE GASTROINTESTINAL TRACT OF MAN. I. CELL RENEWAL IN COLON AND RECTUM. J Clin Invest (1963) 2.27
Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog. Nat Med (1999) 2.14
Genetic control of microsatellite stability. Mutat Res (1997) 1.93
Cancer of the microsatellite mutator phenotype. Biol Chem (1996) 1.91
CELL KINETICS IN THE JEJUNUM AND RECTUM OF MAN. Am J Dig Dis (1964) 1.80
Mechanisms underlying losses of heterozygosity in human colorectal cancers. Proc Natl Acad Sci U S A (2001) 1.68
The kinetics of epithelial cell generation: its relevance to cancer and ageing. J Theor Biol (1999) 1.53
Comparison of spontaneous mutation rates of normal and chemically transformed human skin fibroblasts. Cancer Res (1983) 1.45
Tumour-suppressor genes: evolving definitions in the genomic age. Nat Genet (1997) 1.33
Microsatellite instability and mismatch repair defects in cancer. Mutat Res (1996) 1.25
How many mutations does it take to make a tumor? Proc Natl Acad Sci U S A (1999) 1.20
Natural history of early colorectal cancer. World J Surg (2000) 1.18
Silent and multiple mutations in p53 and the question of the hypermutability of tumors. Carcinogenesis (1997) 0.96
Proliferative activity of human tumors: assessment using bromodeoxyuridine and flow cytometry. Jpn J Cancer Res (1991) 0.87
The consensus coding sequences of human breast and colorectal cancers. Science (2006) 60.02
An integrated genomic analysis of human glioblastoma multiforme. Science (2008) 51.36
The genomic landscapes of human breast and colorectal cancers. Science (2007) 38.12
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science (2008) 36.02
IDH1 and IDH2 mutations in gliomas. N Engl J Med (2009) 32.41
High frequency of mutations of the PIK3CA gene in human cancers. Science (2004) 27.94
Cancer genome landscapes. Science (2013) 25.33
Cancer genes and the pathways they control. Nat Med (2004) 24.22
International network of cancer genome projects. Nature (2010) 20.35
Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature (2010) 17.38
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N Engl J Med (2015) 13.08
Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations. Proc Natl Acad Sci U S A (2003) 12.91
The colorectal microRNAome. Proc Natl Acad Sci U S A (2006) 11.59
Allelic variation in human gene expression. Science (2002) 11.42
Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science (2011) 11.12
Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science (2010) 10.78
Comparative lesion sequencing provides insights into tumor evolution. Proc Natl Acad Sci U S A (2008) 10.52
Circulating mutant DNA to assess tumor dynamics. Nat Med (2007) 10.33
DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science (2011) 10.26
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature (2012) 10.17
DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature (2002) 9.40
Using the transcriptome to annotate the genome. Nat Biotechnol (2002) 9.04
Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med (2014) 8.36
The genetic landscape of the childhood cancer medulloblastoma. Science (2010) 8.34
Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell (2005) 7.87
The PIK3CA gene is mutated with high frequency in human breast cancers. Cancer Biol Ther (2004) 7.82
Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol (2007) 7.46
Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature (2002) 7.46
Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science (2009) 7.39
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci U S A (2013) 6.88
Analysis of the human protein interactome and comparison with yeast, worm and fly interaction datasets. Nat Genet (2006) 6.74
The antisense transcriptomes of human cells. Science (2008) 6.29